date:Jan 31, 2019
naissance BioScience would commercialize their acrylamide-reducing yeast enzyme ingredient, expected to commence in the first quarter of 2019.
This licensing agreement was timely given recent EU acrylamide regulations, which came into force in April 2018, marking the beginning of the law which limits the amount of acrylamide allowed in packaged foods and forces manufacturers to closely examine and reduce acrylamide levels in products.
The legislation describes practical measures based upon be